![Jignesh Shah](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Jignesh Shah
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
R-Pharm US LLC
![]() R-Pharm US LLC Pharmaceuticals: MajorHealth Technology R-Pharm US LLC engages in development and commercialization of medicines to treat cancer. Its products include IXEMPRA and episil. The company was founded by Mark Pavao and Demetrios Kydonieus in 2014 and is headquartered in Princeton, NJ.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jignesh Shah tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
NitroMed, Inc.
![]() NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Sales & Marketing | |
Inhibitex LLC
![]() Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Pharmaceuticals: Major | President | |
Invea Therapeutics, Inc.
![]() Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Settori
Health Technology | 5 |
Posizioni
Director/Board Member | 4 |
Founder | 2 |
President | 2 |
Sales & Marketing | 1 |
Corporate Officer/Principal | 1 |
Contatti più connessi
Insiders | |
---|---|
Demetrios Kydonieus | 4 |
Mark H. Pavao | 2 |
- Borsa valori
- Insiders
- Jignesh Shah
- Connessioni Società